Overview

CODEPAD (Collaborative Outcomes of DEpression and Pain Associated With Delivery)

Status:
Active, not recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
Postnatal depression affects about 10-15% of women after childbirth. Approximately 3-5% of women experience a moderate-to-severe depression that requires medical attention. This study aims to investigate the implication of pain relief choice in reducing the postnatal depression of women who deliver their babies.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
KK Women's and Children's Hospital
Treatments:
Entonox
Fentanyl
Meperidine
Nitrous Oxide
Remifentanil
Ropivacaine